Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium

Lia D'Ambrosio, Marina Tadolini, Rosella Centis, Raquel Duarte, Giovanni Sotgiu, Stefano Aliberti, Masoud Dara, Giovanni Battista Migliori

Research output: Contribution to journalArticle

Abstract

Multi-drug and extensively drug-resistant tuberculosis (MDR/XDR-TB) are considered a serious threat for TB control and elimination. The outcome of these patients is still largely unsatisfactory as of today, with treatment success rates being consistently below 50% at global level. The World Health Organization (WHO) recommends that management of MDR-TB cases is supported by a specialized team, including complementary medical professionals able to cover several perspectives (clinical, both for adults and children; surgical; radiological; public health; psychological; nursing, among others). Implementation of such a body (known as Consilium in most of the former Soviet Union countries) is often a pre-requisite to apply for international TB control funding and concessionally priced medicines to treat M/XDR-TB cases. The primary objective of the ERS/WHO TB Consilium is to provide clinical consultation for drug-resistant TB and other difficult-to-treat TB cases, including co-infection with HIV and paediatric cases. Through technical guidance to clinicians managing complex TB cases, the main contribution and outcome of the initiative will be a public health response aimed at achieving correct treatment of affected patients and preventing further development of drug resistance. The Consilum's secondary objective is to ensure monitoring and evaluation of clinical practices on the ground (diagnosis, treatment and prevention).

Original languageEnglish
Pages (from-to)156-160
Number of pages5
JournalInternational Journal of Infectious Diseases
Volume32
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Extensively Drug-Resistant Tuberculosis
Public Health
USSR
Coinfection
Drug Resistance
Pharmaceutical Preparations
Nursing
Therapeutics
Referral and Consultation
HIV
Pediatrics
Psychology

Keywords

  • Clinical management
  • Drug resistance
  • ERS/WHO Consilium
  • MDR-TB
  • Prevention
  • XDR-TB

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Supporting clinical management of the difficult-to-treat TB cases : The ERS-WHO TB Consilium. / D'Ambrosio, Lia; Tadolini, Marina; Centis, Rosella; Duarte, Raquel; Sotgiu, Giovanni; Aliberti, Stefano; Dara, Masoud; Migliori, Giovanni Battista.

In: International Journal of Infectious Diseases, Vol. 32, 01.03.2015, p. 156-160.

Research output: Contribution to journalArticle

D'Ambrosio, Lia ; Tadolini, Marina ; Centis, Rosella ; Duarte, Raquel ; Sotgiu, Giovanni ; Aliberti, Stefano ; Dara, Masoud ; Migliori, Giovanni Battista. / Supporting clinical management of the difficult-to-treat TB cases : The ERS-WHO TB Consilium. In: International Journal of Infectious Diseases. 2015 ; Vol. 32. pp. 156-160.
@article{71ef801d6e2e4b6fbb26b3ba95036355,
title = "Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium",
abstract = "Multi-drug and extensively drug-resistant tuberculosis (MDR/XDR-TB) are considered a serious threat for TB control and elimination. The outcome of these patients is still largely unsatisfactory as of today, with treatment success rates being consistently below 50{\%} at global level. The World Health Organization (WHO) recommends that management of MDR-TB cases is supported by a specialized team, including complementary medical professionals able to cover several perspectives (clinical, both for adults and children; surgical; radiological; public health; psychological; nursing, among others). Implementation of such a body (known as Consilium in most of the former Soviet Union countries) is often a pre-requisite to apply for international TB control funding and concessionally priced medicines to treat M/XDR-TB cases. The primary objective of the ERS/WHO TB Consilium is to provide clinical consultation for drug-resistant TB and other difficult-to-treat TB cases, including co-infection with HIV and paediatric cases. Through technical guidance to clinicians managing complex TB cases, the main contribution and outcome of the initiative will be a public health response aimed at achieving correct treatment of affected patients and preventing further development of drug resistance. The Consilum's secondary objective is to ensure monitoring and evaluation of clinical practices on the ground (diagnosis, treatment and prevention).",
keywords = "Clinical management, Drug resistance, ERS/WHO Consilium, MDR-TB, Prevention, XDR-TB",
author = "Lia D'Ambrosio and Marina Tadolini and Rosella Centis and Raquel Duarte and Giovanni Sotgiu and Stefano Aliberti and Masoud Dara and Migliori, {Giovanni Battista}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.ijid.2014.12.024",
language = "English",
volume = "32",
pages = "156--160",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Supporting clinical management of the difficult-to-treat TB cases

T2 - The ERS-WHO TB Consilium

AU - D'Ambrosio, Lia

AU - Tadolini, Marina

AU - Centis, Rosella

AU - Duarte, Raquel

AU - Sotgiu, Giovanni

AU - Aliberti, Stefano

AU - Dara, Masoud

AU - Migliori, Giovanni Battista

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Multi-drug and extensively drug-resistant tuberculosis (MDR/XDR-TB) are considered a serious threat for TB control and elimination. The outcome of these patients is still largely unsatisfactory as of today, with treatment success rates being consistently below 50% at global level. The World Health Organization (WHO) recommends that management of MDR-TB cases is supported by a specialized team, including complementary medical professionals able to cover several perspectives (clinical, both for adults and children; surgical; radiological; public health; psychological; nursing, among others). Implementation of such a body (known as Consilium in most of the former Soviet Union countries) is often a pre-requisite to apply for international TB control funding and concessionally priced medicines to treat M/XDR-TB cases. The primary objective of the ERS/WHO TB Consilium is to provide clinical consultation for drug-resistant TB and other difficult-to-treat TB cases, including co-infection with HIV and paediatric cases. Through technical guidance to clinicians managing complex TB cases, the main contribution and outcome of the initiative will be a public health response aimed at achieving correct treatment of affected patients and preventing further development of drug resistance. The Consilum's secondary objective is to ensure monitoring and evaluation of clinical practices on the ground (diagnosis, treatment and prevention).

AB - Multi-drug and extensively drug-resistant tuberculosis (MDR/XDR-TB) are considered a serious threat for TB control and elimination. The outcome of these patients is still largely unsatisfactory as of today, with treatment success rates being consistently below 50% at global level. The World Health Organization (WHO) recommends that management of MDR-TB cases is supported by a specialized team, including complementary medical professionals able to cover several perspectives (clinical, both for adults and children; surgical; radiological; public health; psychological; nursing, among others). Implementation of such a body (known as Consilium in most of the former Soviet Union countries) is often a pre-requisite to apply for international TB control funding and concessionally priced medicines to treat M/XDR-TB cases. The primary objective of the ERS/WHO TB Consilium is to provide clinical consultation for drug-resistant TB and other difficult-to-treat TB cases, including co-infection with HIV and paediatric cases. Through technical guidance to clinicians managing complex TB cases, the main contribution and outcome of the initiative will be a public health response aimed at achieving correct treatment of affected patients and preventing further development of drug resistance. The Consilum's secondary objective is to ensure monitoring and evaluation of clinical practices on the ground (diagnosis, treatment and prevention).

KW - Clinical management

KW - Drug resistance

KW - ERS/WHO Consilium

KW - MDR-TB

KW - Prevention

KW - XDR-TB

UR - http://www.scopus.com/inward/record.url?scp=84922996783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922996783&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2014.12.024

DO - 10.1016/j.ijid.2014.12.024

M3 - Article

C2 - 25809773

AN - SCOPUS:84922996783

VL - 32

SP - 156

EP - 160

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -